CELG
Celgene Corporation

12,276
Loading...
Loading...
News
all
press releases
Bristol Myers Squibb (NYSE:BMY) Earns Buy Rating from Guggenheim
Guggenheim reaffirmed a "buy" rating and set a $72.00 price target on shares of Bristol Myers Squibb in a research note on Wednesday...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Cantor Fitzgerald Forecasts Strong Price Appreciation for Bristol Myers Squibb (NYSE:BMY) Stock
Cantor Fitzgerald boosted their target price on Bristol Myers Squibb from $45.00 to $54.00 and gave the company a "neutral" rating in a research report on Wednesday...
MarketBeat·23h ago
News Placeholder
Daytona Street Capital LLC Makes New $1.36 Million Investment in Bristol Myers Squibb Company $BMY
Daytona Street Capital LLC bought a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) during the fourth quarter, according to its most recent filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Perpetual Ltd Purchases 36,562 Shares of Bristol Myers Squibb Company $BMY
Perpetual Ltd raised its position in shares of Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 121.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,741 shares of the biopharmaceutical comp...
MarketBeat·4d ago
News Placeholder
SteelPeak Wealth LLC Purchases New Holdings in Bristol Myers Squibb Company $BMY
SteelPeak Wealth LLC acquired a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 36,357 shares of the biopharmaceutical company's stock, valued at approximately $1,961,000...
MarketBeat·4d ago
News Placeholder
Trust Co. of Toledo NA OH Sells 55,523 Shares of Bristol Myers Squibb Company $BMY
Trust Co. of Toledo NA OH reduced its position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 35.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 103,227 shares of the biopharmaceutical company's...
MarketBeat·5d ago
News Placeholder
Global Trust Asset Management LLC Has $1.47 Million Position in Bristol Myers Squibb Company $BMY
Global Trust Asset Management LLC raised its stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 2,916.2% during the 4th quarter, according to the company in its most recent 13F filing...
MarketBeat·5d ago
News Placeholder
Element Squared LLC Acquires Shares of 48,420 Bristol Myers Squibb Company $BMY
Element Squared LLC bought a new position in Bristol Myers Squibb Company (NYSE:BMY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The...
MarketBeat·5d ago
News Placeholder
Bristol Myers Squibb (NYSE:BMY) EVP David Elkins Sells 30,000 Shares
Bristol Myers Squibb Company (NYSE:BMY - Get Free Report) EVP David Elkins sold 30,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of...
MarketBeat·6d ago
News Placeholder
Bristol Myers Squibb Company $BMY Shares Bought by FNY Investment Advisers LLC
FNY Investment Advisers LLC grew its stake in Bristol Myers Squibb Company (NYSE:BMY - Free Report) by 1,170.7% in the fourth quarter, according to its most recent 13F filing with the Securities...
MarketBeat·6d ago
<
1
2
...
>

Latest CELG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.